Loading…
* Free cash flow = OCF − net investing outflow (the filings carry no standalone capex line).
Operates in Healthcare Services — In-patient & out-patient services. Per the activity note to the FY2020 annual report, the company provides specialized and general medical practice and healthcare. Founded on 29 October 1998; provides specialized medical, general medical practice, and healthcare services.
| Ratio | 2017 | 2018 | 2019 | 2020 |
|---|---|---|---|---|
| Margins | ||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% |
| EBITDA Margin | 32.3% | 37.3% | 10.7% | -29.0% |
| EBITDAR | 2,231 | 3,299 | 854 | 123 |
| EBITDAR Margin | 38.8% | 44.1% | 13.0% | 13.6% |
| EBIT Margin | 28.3% | 33.8% | -2.7% | -38.3% |
| Net Profit Margin | 33.8% | 35.4% | -25.7% | 233.3% |
| Operating Expense % of Sales | 67.7% | 62.7% | 89.3% | 129.0% |
| Returns | ||||
| Return on Assets (ROA) | 76.8% | 68.4% | -44.6% | 234.5% |
| Return on Equity (ROE) | N/A | N/A | N/A | N/A |
| ROIC [EBIT / Invested Capital] | 105.2% | 100.0% | -11.9% | N/A |
| Leverage & debt balances | ||||
| Debt-to-Assets | 219.8% | 135.0% | 154.0% | 65.9% |
| Debt-to-Equity | -1.39x | -1.97x | -1.34x | -0.26x |
| Debt-to-EBITDA | 3.00x | 1.87x | 8.33x | N/A |
| Equity-to-Assets | -158.2% | -68.4% | -114.8% | -250.7% |
| Net Debt | 5,548 | 5,181 | 5,823 | 589 |
| Cash & Equivalents | 16 | 55 | 2 | 0 |
| Total Debt | 5,565 | 5,236 | 5,825 | 590 |
| Liquidity & working capital | ||||
| Current Ratio | 0.96x | 0.82x | 0.40x | 0.13x |
| Quick Ratio | 0.96x | 0.82x | 0.40x | 0.13x |
| Cash Ratio | 0.02x | 0.03x | 0.00x | 0.00x |
| Total Current Assets | 761 | 1,520 | 1,458 | 339 |
| Total Current Liabilities | 791 | 1,865 | 3,644 | 2,548 |
| Inventory | N/A | N/A | N/A | N/A |
| Trade Receivables | 695 | 923 | 641 | 71 |
| Trade Payables | 299 | 882 | 1,093 | 1,206 |
| Net Working Capital | -31 | -345 | -2,186 | -2,209 |
| Net Working Capital % of Revenue | -0.5% | -4.6% | -33.3% | -245.7% |
| Trade Working Capital | 396 | 41 | -452 | -1,135 |
| Trade Working Capital % of Revenue | 6.9% | 0.6% | -6.9% | -126.3% |
| Change in Trade Working Capital | N/A | -355 | -493 | -683 |
| Turnover & efficiency | ||||
| Inventory Turnover | N/A | N/A | N/A | N/A |
| Days Inventory Outstanding (DIO) | N/A | N/A | N/A | N/A |
| Receivables Turnover | 8.27x | 8.11x | 10.24x | 12.73x |
| Days Sales Outstanding (DSO) | 44.2 | 45.0 | 35.6 | 28.7 |
| Payables Turnover | N/A | N/A | N/A | N/A |
| Days Payable Outstanding (DPO) | N/A | N/A | N/A | N/A |
| Cash Conversion Cycle | 44.2 days | 45.0 days | 35.6 days | 28.7 days |
| Asset Turnover | 2.27x | 1.93x | 1.74x | 1.01x |
| Cash flow & dividends | ||||
| Operating Cash Flow | 2,665 | 3,073 | N/A | N/A |
| Free Cash Flow (OCF − Capex proxy) | 2,665 | 941 | N/A | N/A |
| Cash Conversion (OCF / EBITDA) | 143.7% | 110.0% | N/A | N/A |
| Dividends Declared | N/A | N/A | N/A | N/A |
| Dividend Payout Ratio | N/A | N/A | N/A | N/A |
Money rows — EBITDAR, net debt, cash, total debt, operating and free cash flow, dividends declared — are in GEL, thousands. Margins, returns and payout are percentages; turnover and leverage are multiples; DIO/DSO/DPO are days. Hover a metric name for its definition.
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →